Australia Rotavirus Vaccine Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4170

  • Format: PPT, PDF

Australia Rotavirus Vaccines Market: Segmented by Type (Rotarix (GlaxoSmithKline Australia), RotaTeq (Merck Sharp & Dohme), & Others), by End Users (Hospital & Clinics, Academic & Research, & Others)- Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The Australia Rotavirus Vaccines market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Rotavirus infection was the most common cause of severe gastroenteritis in infants and young children. Rotavirus infection can cause severe viral gastroenteritis in infants and children. Before vaccination became available in Australia, rotavirus caused up to half of all hospitalized cases of gastroenteritis in children younger than five years of age. The illness usually begins suddenly with vomiting followed by diarrhea. Rotavirus infection can result in dehydration and hospitalization. All infants <6 months of age are recommended to receive a course of oral rotavirus vaccine (Rotarix or RotaTeq). The vaccination course of Rotarix is 2 doses, at 2 and 4 months of age. The vaccination course of RotaTeq is 3 doses, at 2, 4, and 6 months of age. Infants and children can be infected with rotavirus several times during their lives. Rotavirus vaccination significantly reduces rotavirus-specific and all-cause hospital presentations for gastroenteritis.

Market Drivers

An increase in awareness regarding vaccines among patients can accelerate the growth of this market. The rise in the population of immunity-compromised individuals can act as a catalyst for market growth. An increase in the development and manufacturing of vaccines would enhance the market growth. The birth rate for Australia in 2019 was 12.720 births per 1000 people, a 1.23% decline from 2018. The birth rate for Australia in 2018 was 12.879 births per 1000 people, a 0.77% decline from 2017.

Epidemiology of ROTAVIRUS

Infection in early childhood is thought to be universal in unvaccinated children. People can be infected several times in their lives. The first infection, which typically occurs between 3 and 36 months of age, is most likely to cause severe diarrhea and dehydration.

The degree of protection after natural infection varies. After a single natural infection:

  • 40% of children are protected against any subsequent infection with rotavirus.
  • 75% are protected against diarrhea from subsequent rotavirus infection.
  • 88% are protected against severe diarrhea caused by rotavirus.

Rotavirus vaccines were added to the National Immunisation Program in 2007. Before this, about 10,000 children <5 years of age were hospitalised because of rotavirus each year in Australia. This equated to around half of all hospitalizations for acute gastroenteritis in this age group. Rotavirus affected about 3.8% of all children (1 in 27) by the age of 5 years.

In temperate Australia, rotavirus infections follow a seasonal pattern. The peak incidence is in mid to late winter.

The northern tropical and arid regions do not show a consistent seasonal pattern. Disease peaks are unpredictable, and widespread epidemics cause severe strain on healthcare services.


1. Australia Rotavirus Vaccines Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Increase in the Awareness Regarding Vaccines
B. Increase in the Development and Manufacturing of Vaccine
C. Rise in the Population
3. Epidemiology of Rotavirus………………………………………………….
A. Natural infection and immunity
B. Hospitalisation and deaths
C. Patterns of rotavirus infection
4. Rotavirus Vaccines Market Segmentation………………………………………
A. Type
I. Rotarix (GlaxoSmithKline Australia)
II. RotaTeq (Merck Sharp & Dohme)
III. Others
B. End Users
I. Hospital & Clinics
II. Academic & Research
III. Others
5. Rotavirus Vaccines Major Drugs Market Share………………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. GlaxoSmithKline plc Company overview, Product & Services, Strategies & Financials
B. Merck & Co Company overview, Product & Services, Strategies & Financials
C. Sanofi, Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of Rotavirus Vaccines market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type:

By the Type of Rotavirus, the Australian market is segmented into Rotarix, RotaTeq, & others.

Rotarix (human monovalent rotavirus vaccine)- is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9).

The vaccination course of Rotarix is 2 doses, at 2 and 4 months of age. Give the 1st dose between 6 and 14 weeks of age — that is, before turning 15 weeks old. Give the 2nd dose by 24 weeks of age — that is, before turning 25 weeks old. Ensure that the interval between the 2 doses is at least 4 weeks.

RotaTeq (pentavalent human–bovine reassortant rotavirus vaccine)- is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9.

The vaccination course of RotaTeq is 3 doses, at 2, 4, and 6 months of age. Give the 1st dose between 6 and 12 weeks of age — that is, before turning 13 weeks old. Give the 2nd dose at least 4 weeks later. Give the 3rd dose by 32 weeks of age — that is, before turning 33 weeks old. Ensure that the interval between doses 2 and 3 is at least 4 weeks.

By End-users:

Based on the end-users, the market has been segmented as hospitals & clinics, academic and research, and others. Among the above-mentioned segments hospitals & clinics have the having the market share, owing to people prefer hospitals and clinics to other segments for vaccinating their infants.

Major Players

The rise in the birth rate of the Australian country and further development in the product pipeline to meet the edge and corners of the market propel the growth of the market. Some of the key players profiled for the Australian rotavirus vaccine market are Merck & Co., GlaxoSmithKline plc., Sanofi, and others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements